What did @gaps.__ actually say?
The creator tried Lemon Bottle injections on her upper arms for what she called stubborn fat, combined it with radiofrequency (RF) treatments, and reported her arms feel "a bit lighter" nearly a month later. She was honest that "this isn't a shortcut" and that results depend on lifestyle, noting she had also started eating healthier and working out again. She rated the pain a 4 out of 10, described it as feeling like ant bites, and said full results take "around 4 to 6 weeks." That's a reasonably grounded set of claims for a cosmetic treatment video.
She did not claim dramatic fat loss. She did not say it replaces diet or exercise. And she disclosed the treatment was done by a doctor. Those are all things that often go missing in this category of content.
Does the science back this up?
Partially, but with significant caveats. Lemon Bottle contains deoxycholic acid as its active lipolytic agent, along with riboflavin and bromelain. Deoxycholic acid is the only injectable fat-reduction ingredient with FDA approval, specifically Kybella (ATX-101), which is approved for submental fat only. The evidence for deoxycholic acid works by disrupting adipocyte membranes, causing cell lysis. Dayan et al. (2016, Aesthetic Surgery Journal) confirmed efficacy for chin fat reduction in Phase 3 trials.
The problem is Lemon Bottle itself has no published clinical trials. It is marketed primarily in the UK, Southeast Asia, and the Philippines. No peer-reviewed study has evaluated its specific formulation, dosing protocol, or safety profile for arm fat. Bromelain has anti-inflammatory properties but no established lipolytic role in injectable form. Riboflavin adds nothing scientifically defensible to a fat-dissolving mechanism. The arms are also not a validated treatment site for any deoxycholic acid product.
What did they get wrong (or right)?
Credit where it's due: the creator got several things right. Acknowledging lifestyle changes matter, being upfront that results take weeks, and having a doctor administer the treatment are all responsible disclosures. The 4 to 6 week timeline for visible changes is consistent with how deoxycholic acid works, fat cell debris is cleared via the lymphatic system over weeks, not days.
What's missing or misleading: the video is categorized under GLP-1 content, but Lemon Bottle has no relationship to GLP-1 receptor agonists. More importantly, the creator doesn't address that Lemon Bottle is not approved by the FDA, is not approved by the Philippine FDA (as of available public data), and has no clinical evidence for arm fat specifically. The combination with RF is common in aesthetic clinics but the additive benefit of RF plus lipolytic injections is also not well-studied. Consumers watching this may not realize they're looking at an off-label, unregulated product being used at an off-label body site.
What should you actually know?
If you are considering any injectable fat-reduction treatment, the only FDA-approved option for any body site is Kybella for under the chin. Every other deoxycholic acid or lipolytic product, including Lemon Bottle, operates outside that regulatory framework. That doesn't automatically make them dangerous, but it does mean you're accepting more unknown risk. The adverse event profile of deoxycholic acid injections includes nerve injury, skin ulceration, and uneven tissue loss. These outcomes are documented even with the studied formulation, Jones et al. (2016, Dermatologic Surgery) reported nerve injury rates in submental injection trials.
- Lemon Bottle is not FDA-approved for any indication.
- Its arm fat application is off-label even within markets where it is sold.
- No published clinical trial has evaluated this specific formulation.
- RF may offer mild skin tightening benefits, but the evidence for its fat reduction effect is weak and inconsistent.
- Results that feel like progress at three weeks may be inflammation and swelling reduction, not actual fat loss. The fat clearance timeline is real, but early subjective impressions can be misleading.
Is the GLP-1 category label accurate here?
No, and this matters. Lemon Bottle is a locally injected cosmetic product. GLP-1 receptor agonists like semaglutide or tirzepatide are systemic medications that work through metabolic and appetite-regulating pathways, they have nothing to do with injectable lipolysis. Categorizing this content under GLP-1 conflates two completely different treatment classes. Consumers looking for information on medically supervised weight management drugs should not be directed to or confused by cosmetic injection content. These are not comparable or interchangeable approaches.